Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
[Immunomodulation and neuroprotection in optic neuritis].
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
The use of hematopoietic stem cells in autoimmune diseases.
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Overview of the immune system.
Effect of vitamin D on MS activity by disease-modifying therapy class.
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
Fatigue and Comorbidities in Multiple Sclerosis.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
Extended interval dosing of natalizumab in multiple sclerosis.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Epigenetics of Multiple Sclerosis: An Updated Review.
Brain and BrainPET 2015
Biogen Idec receives notification of PDUFA date extension
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
Autoimmune sleep disorders.
Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis

Pages